Evidence map›Paper›PMID 42645792›Full record

ArticleHematology reports2026

Diminished Prognostic Value of Interim PET in Hodgkin Lymphoma Treated with Brentuximab Vedotin Plus AVD: A Retrospective Analysis.

Kareem Latif, Isaiah Courtad, Avery Stuart, Faisal Ansari, Ravand Samaeekia, Mojtaba Akhtari

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Hematology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kareem LatifDepartment of Medicine, Loma Linda University School of Medicine, Loma Linda University Medical Center, Loma Linda, CA 92350, USA.ORCID 0000-0002-2417-7981
Isaiah CourtadSchool of Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
Avery StuartSchool of Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
Faisal AnsariDepartment of Medicine, Loma Linda University School of Medicine, Loma Linda University Medical Center, Loma Linda, CA 92350, USA.ORCID 0009-0000-1039-7169
Ravand SamaeekiaDepartment of Medicine, Division of Hematology/Oncology, University of California Irvine, Irvine, CA 92868, USA.
Mojtaba AkhtariDepartment of Medicine, Division of Transplant, Cellular Therapy, and Hematological Malignancies, Loma Linda University School of Medicine, Loma Linda University Medical Center, Loma Linda, CA 92350, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

brentuximab vedotinHodgkin lymphomapositron emission tomographyresponse-adapted therapy

Identifiers

PMID42645792
PMCPMC13512761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.